RE:RE:RE:RE:RE:RE:Failure, again.Tencents wrote: Indeed - true about Avalyn
but note it took 13 years to get there and they have about 6 candidates in this area
Still have years to go to get a product in the market
CZO's market cap is only C$20 million. Avalyn raised C$80 million going into its Phase I. What do you think Avalyn's market cap was going into Phase I given it raised C$80 million cash going into Phase I. CZO appears a short toxicology study away from declaring a Phase I clinical trial. CZO's drug also has the COVID opportunity which Avalyn didn't have when it raised C$80 million. CZO's drug could be used beyond lung fibrosis. 40% of deaths worldwide involve fibrosis Dr. Ask noted. CZO's carrier could also be used for other drugs beyond fibrosis such as for delivering an epilepsy drug Gilles once noted. With a $20 million market cap we may not have to wait long for a payout with the stock; certainly not 13 years. Given the applications for COVID CZO could even find an accelerated path to approval.